CHG-2023-0246

New Dosage Strength for Dupitumacon. Analytical Method Change for Dupitumacon — minor update. Impacts 8 markets and 4 variations.

Change Number
CHG-2023-0246
Type
New Dosage Strength
Product
Dupitumacon
Status
Overdue
Owner
Tomoko Ikeda
Initiated
2024-02-02
Description

Analytical Method Change for Dupitumacon — minor update

Impacted Markets (8)
IT — ItalyES — SpainAR — ArgentinaZA — South AfricaPL — PolandSE — SwedenAT — AustriaDK — Denmark
Impacted Modules
4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved